Throughout the last three months, 4 analysts have evaluated Corcept Therapeutics (NASDAQ:CORT), offering a diverse set of opinions from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 0 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 2 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $40.5, a high estimate of $44.00, and a low estimate of $38.00. Observing a 1.25% increase, the current average has risen from the previous average price target of $40.00.
Diving into Analyst Ratings: An In-Depth Exploration
The standing of Corcept Therapeutics among financial experts becomes...
ログインすると全部閲覧できます。
ログイン